Table 2.
Immunohistochemical analysis of ERGIC3 in various tumor tissues by using mAb 6-C4
Cancer | ERGIC3 staining |
---|---|
Non-small cell lung cancer (NSCLC) | 21/22 |
Pancreatic carcinoma | 4/4 |
Hepatocellular carcinoma (HCC) | 4/4 |
Gastric carcinoma | 4/4 |
Esophagus carcinoma | 10/10 |
Colorectal carcinoma | 5/5 |
Renal cell carcinoma | 9/9 |
Bladder carcinoma | 11/12 |
Mammary carcinoma | 5/6 |
Cervical carcinoma | 9/10 |
Prostate cancer | 9/11 |
Thyroid carcinoma | 5/5 |
Osteosarcoma | 0/3 |
Chondrosarcoma | 0/2 |
Fibrosarcoma | 0/3 |